Amiram Goldblum (born 1945 in Rosh Pinna, Israel) is a computational medicinal chemist and Professor Emeritus at the Hebrew University of Jerusalem School of Pharmacy. He served as an IDF soldier, including in the 1973 Yom Kippur War. Throughout his academic career, he headed the Molecular Modeling and Drug Design unit at the Hebrew University’s Institute for Drug Research, where his work focused on viral protease inhibitors and drug discovery methods. He developed the Iterative Stochastic Elimination (ISE) algorithm, a computational breakthrough that earned him the Kaye Innovation Prize in 2017 and led to commercial biotechnology applications such as Pepticom.
Alongside his scientific work, Goldblum has a long-standing public profile as an anti-war and human rights activist in Israel. As a military veteran, he frequently challenges conventional state security narratives, arguing that the military occupation of Palestine undermines Israel’s long-term security and moral standing. He is a prominent member of Academia for Equality (an organization of Israeli university faculty advocating for civil rights, democracy, and equality).
Goldblum’s public advocacy includes opposing the occupation, criticizing government policies, and supporting targeted academic and institutional boycotts, including principles aligned with the BDS movement. Highlighting the severity of the humanitarian crisis, he was among the signatories of an open letter titled “The starvation of Gaza is shameful. Crippling sanctions on Israel are needed.”